我的生活+的主要目标之一是帮助人们预防新的HIV和其他STI，丙型肝炎和结核病病历的产生。

该应用程序有助于建立医生和HIV感染者之间的匿名沟通。它可以让您创建简单易行的服药时间表，并设置隐藏和个性化的提醒。

全部新闻 / 十二月 2016

归档

✕

13 十二月 2016

4368

USA: Still a disparity of viral suppression rates between race/ethnic groups

USA: Still a disparity of viral suppression rates between race/ethnic groups

The Medical Monitoring Project has collected information since 2005 from people across 16 states and 1 U.S. territory (Puerto Rico) who attend HIV care facilities. A group of researchers analyzed the data from the Medical Monitoring Project between 2009 and 2013 to figure ...

12 十二月 2016

4114

Study: More and more HIV patients with multiple drug resistance

Study: More and more HIV patients with multiple drug resistance

New study was published in the November issue of The Lancet Infectious Disease journal. According to it 80 percent of HIV patients who have drug resistance to older ARV medications called thymidine analogues were also resistant to tenofovir. Tenofovir now is a main drug ...

11 十二月 2016

4539

Study: Stigma still a big barier in PrEP uptake

Study: Stigma still a big barier in PrEP uptake

The investigators from the United Kingdom have reported the results of their study which was designed to figure out why many men decline to use pre-exposure prophylaxis (PrEP) (Truvada). PrEP is a highly effective drug to reduce the risk of aquiring HIV for those who are ...

9 十二月 2016

4037

Mobil app for HIV-positive youth supports adherence

Mobil app for HIV-positive youth supports adherence

The National Institutes for Health has funded a study to develop an new mobile app called “Youth Thrive” which might help young people living with HIV to take their medications by sending them reminders. A team of researchers from across the US will conduct focus groups ...

9 十二月 2016

6693

Charlie Sheen reveals he achieves HIV suppression by experimental medication

Charlie Sheen reveals he achieves HIV suppression by experimental medication

In his exclusive interview with the Daily Mail Online, the 51-year-old actor stated that his viral load is completely suppressed by taking PRO 140, an injectable HIV drug that's currently being studied. The actor has been involved in a clinical trial since the beginning ...

8 十二月 2016

4491

Children’s cough virus might help to fight liver cancer and Hep C

Children’s cough virus might help to fight liver cancer and Hep C

The University of Leeds team have published early-stage results of their research in the journal Gut. According to the research Reovirus which causes coughs and colds and upset stomachs in children could help in the fight against primary liver cancer and also kill off the ...

8 十二月 2016

4309

Increase of HIV drug resistance might pose a major threat to global effort to stop the disease

Increase of HIV drug resistance might pose a major threat to global effort to stop the disease

Despite the success in putting more and more people on antiretroviral therapy (ART) that suppresses the virus in a patient’s blood and dramatically decreases the risk of transmission, another alarming trend is starting to play an important role in the fight against HIV. ...

8 十二月 2016

3969

Philippines: access to HIV prevention is a problem for MSM

Philippines: access to HIV prevention is a problem for MSM

Human Rights Watch (HRW) has published a report which stated that the prevalence of HIV among men who have sex with men in the Philippines has increased tenfold over the last five years and the country is not doing enough to improve access to HIV prevention programs such ...

7 十二月 2016

4113

United States: Syringe service works but still not used enough

United States: Syringe service works but still not used enough

The US Centers for Disease Control and Prevention (CDC) has published the latest Vital Signs report as part of the online edition of CDC’s Morbidity and Mortality Report on November 29. According to the Report, HIV diagnoses among people who inject drugs have fallen by ...

7 十二月 2016

4278

Shock-and-kill approach might pose danger to HIV patients' brains

Shock-and-kill approach might pose danger to HIV patients' brains

The idea of the so-called “shock-and -kill” strategy is to use latency-reversing agents to wake up dormant viruses in the body and make them vulnerable to the immune system first and then to use antiretroviral (ARV) drugs to wipe out the majority of infected cells. A group ...

1 2 3 4 5